Apexa Bernard

Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer

C. Kollmannsberger, K. Chi, T. Griffin, 2015, Journal of clinical pharmacology.

Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer

A. Tolcher, B. Kaiser, A. Patnaik, 2012, Cancer Chemotherapy and Pharmacology.

Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men

R. Vries, A. Bernard, M. Acharya, 2012, Cancer Chemotherapy and Pharmacology.

In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity

J. Snoeys, J. Jiao, J. Monbaliu, 2016, Drug Metabolism and Disposition.

IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES TO ASSESS THE EFFECT OF ABIRATERONE ACETATE , ABIRATERONE , AND METABOLITES OF ABIRATERONE ON CYP 2 C 8 ACTIVITYa

J. Snoeys, A. Bernard, J. Jiao, 2016 .

Impact on abiraterone pharmacokinetics and safety: Open‐label drug–drug interaction studies with ketoconazole and rifampicin

A. Bernard, N. Vaccaro, M. Acharya, 2015, Clinical pharmacology in drug development.

Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing

A. Bernard, N. Vaccaro, J. Jiao, 2014, Cancer Chemotherapy and Pharmacology.

Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development

Holly Kimko, Italo Poggesi, Dinesh Mital, 2012, Expert opinion on drug metabolism & toxicology.